-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Qh4Zv15wR7Q+Ce+nCy+pXbl3bEED16qowbbAyzN8upkSsqJtF+1XD4+fy4Hle+C5 okmw+WDfiu5jgqJkx5e5Ww== 0000950133-99-001980.txt : 19990521 0000950133-99-001980.hdr.sgml : 19990521 ACCESSION NUMBER: 0000950133-99-001980 CONFORMED SUBMISSION TYPE: 13F-HR/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19990331 FILED AS OF DATE: 19990520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BB BIOTECH AG CENTRAL INDEX KEY: 0000924223 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] STATE OF INCORPORATION: DC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR/A SEC ACT: SEC FILE NUMBER: 028-06964 FILM NUMBER: 99631245 BUSINESS ADDRESS: STREET 1: C/O BAKER & MCKENZIE STREET 2: 815 CONNECTICUT AVENUE NW CITY: WASHINGTON STATE: DC ZIP: 20006 BUSINESS PHONE: 2028351882 MAIL ADDRESS: STREET 1: C/O BAKER & MCKENZIE STREET 2: 815 CONNECTICUT AVENUE NW CITY: WASHINGTON STATE: DC ZIP: 20006 13F-HR/A 1 FORM 13F 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for Calendar Year or Quarter Ended: March 31, 1999 Check here if Amendment [ X ]; Amendment Number: 1 This Amendment (Check only one.): [ X ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: BB Biotech AG Address: Vordergasse 3 Grafenauweg 4 Zug, Switzerland CH-6301 Form 13F File Number: 28-6964 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Daniel Bugmann Title: SIGNING AUTHORITY ------------------ Phone: (41-41) 724-5959 Signature, Place, and Date of Signing: /s/ DANIEL BUGMANN Zug, Switzerland 18 May 1999 - ---------------------- 2 Report Type (Check only one.): [ ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [XX] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: Name Biotech Focus S.A. Biotech Invest S.A. 3 Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 2 Form 13F Information Table Entry Total: 13 Form 13F Information Table Value Total:$820,218 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Name 1 Biotech Focus S.A. 2 Biotech Invest S.A. 4 BB BIOTECH AG 31-MAR-99 FORM 13F INFORMATION TABLE
- ----------------------------------------------------------------------------------------------------------------------------------- COLUMN 8: COLUMN 5: VOTING AUTHORITY COLUMN 4: COLUMN 6: COLUMN 1: COLUMN 2: COLUMN 3: VALUE ------------------------ INVESTMENT COLUMN 7: --------------------------- NAME OF ISSUER TITLE OF CLASS CUSIP (X$1,000) SHRS OR SH/ PUT/ DISCRETION OTHER PRN AMT PRN CALL MANAGERS SOLE SHARED NONE - ----------------------------------------------------------------------------------------------------------------------------------- Alexion Pharmaceuticals, Inc. Common Stock 01535110 $ 15,396 1,824,113 SH DEFINED 2 1,824,113 NONE NONE - ----------------------------------------------------------------------------------------------------------------------------------- Algos Pharmaceuticals, Inc. Common Stock 01586910 $ 4,001 1,165,000 SH DEFINED 1,165,000 NONE NONE - ----------------------------------------------------------------------------------------------------------------------------------- Ariad Pharmaceuticals Inc. Common Stock 04033A10 $ 3,205 2,273,000 SH DEFINED 2 2,273,000 NONE NONE - ----------------------------------------------------------------------------------------------------------------------------------- Aurora Biosciences, Inc. Common Stock 05192010 $ 9,552 1,421,500 SH DEFINED 2 1,421,500 NONE NONE - ----------------------------------------------------------------------------------------------------------------------------------- Aviron Common Stock 05376210 $ 53,770 2,655,286 SH DEFINED 2 2,655,286 NONE NONE - ----------------------------------------------------------------------------------------------------------------------------------- Biochem Pharma, Inc. Common Stock 09058T10 $ 108,095 5,072,500 SH DEFINED 1 5,072,500 NONE NONE - ----------------------------------------------------------------------------------------------------------------------------------- Centocor Common Stock 15234210 $ 3,615 910,000 SH DEFINED 910,000 NONE NONE - ----------------------------------------------------------------------------------------------------------------------------------- CV Therapeutics, Inc. Common Stock 12666710 $ 9,612 1,969,647 SH DEFINED 2 1,969,647 NONE NONE - -----------------------------------------------------------------------------------------------------------------------------------
5 - ----------------------------------------------------------------------------------------------------------------------------------- La Jolla Pharmaceutical Company Common Stock 50345910 $ 789 3,001,000 SH DEFINED 2 3,001,000 NONE NONE - ----------------------------------------------------------------------------------------------------------------------------------- MedImmune Common Stock 58469910 $ 437,177 7,386,000 SH DEFINED 1 7,386,000 NONE NONE - ----------------------------------------------------------------------------------------------------------------------------------- Sangstat Medical Corp. Common Stock 80100310 $ 5,323 430,000 SH DEFINED 430,000 NONE NONE - ----------------------------------------------------------------------------------------------------------------------------------- Transkaryotic Therapies Common Stock 89373510 $ 89,265 2,811,500 SH DEFINED 2 2,811,500 NONE NONE - ----------------------------------------------------------------------------------------------------------------------------------- Vertex Pharmaceuticals, Inc. Common Stock 92532F10 $ 19,064 755,000 SH DEFINED 2 755,000 NONE NONE - ----------------------------------------------------------------------------------------------------------------------------------- COLUMN TOTALS $ 820,218 - -----------------------------------------------------------------------------------------------------------------------------------
-----END PRIVACY-ENHANCED MESSAGE-----